BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26925685)

  • 1. Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India.
    Gorre M; Mohandas PE; Kagita S; Cingeetham A; Vuree S; Jarjapu S; Nanchari S; Meka PB; Annamaneni S; Dunna NR; Digumarti R; Satti V
    Asian Pac J Cancer Prev; 2016; 17(2):815-21. PubMed ID: 26925685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
    Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
    Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
    Song CM; Kwon TK; Park BL; Ji YB; Tae K
    Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
    Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
    BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia.
    Yaya K; Hind D; Meryem Q; Asma Q; Said B; Sellama N
    Tumour Biol; 2014 Nov; 35(11):10969-75. PubMed ID: 25087925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the role of the ATM gene in chronic myeloid leukaemia.
    Melo JV; Kumberova A; van Dijk AG; Goldman JM; Yuille MR
    Leukemia; 2001 Sep; 15(9):1448-50. PubMed ID: 11516106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India.
    Annamaneni S; Gorre M; Kagita S; Addepalli K; Digumarti RR; Satti V; Battini MR
    Hematology; 2013 May; 18(3):163-8. PubMed ID: 23320983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
    Sailaja K; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.
    Agostini LP; Stur E; Garcia FM; Ventorim DP; Dos Reis RS; Dettogni RS; Dos Santos EVW; Peterle GT; Maia LL; Mendes SO; de Carvalho MB; Tajara EH; de Paula F; Dos Santos M; da Silva AMA; Louro ID
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):727-735. PubMed ID: 29135311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
    Salimizand H; Amini S; Abdi M; Ghaderi B; Azadi NA
    Tumour Biol; 2016 Jan; 37(1):791-8. PubMed ID: 26250462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia.
    Sailaja K; Surekha D; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(2):461-4. PubMed ID: 20843134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
    Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
    Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
    Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
    Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
    Bedewy AM; El-Maghraby SM
    Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
    Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M
    Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between methylenetetrahydrofolate reductase polymorphism C677T and risk of chronic myeloid leukemia in Serbian population.
    Jakovljevic K; Malisic E; Cavic M; Radulovic S; Jankovic R
    Leuk Lymphoma; 2012 Jul; 53(7):1327-30. PubMed ID: 22132838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
    Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
    Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.